01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $6.29B
1 older move runs past ±150% (largest +1023.8%); point at, tap or drag across the bars to read one.
02—Ledger
Long-Term Debt, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $6.29B | +38.3% | 10-K | |
| FY2024 | $4.55B | −33.0% | 10-K | |
| FY2023 | $6.79B | +8.1% | 10-K | |
| FY2022 | $6.28B | +0.1% | 10-K | |
| FY2021 | $6.27B | −15.5% | 10-K | |
| FY2020 | $7.43B | +66.5% | 10-K | |
| FY2019 | $4.46B | −24.9% | 10-K | |
| FY2018 | $5.94B | 0.0%flat | 10-K | |
| FY2017 | $5.93B | −8.9% | 10-K | |
| FY2016 | $6.51B | −0.1% | 10-K | |
| FY2015 | $6.52B | +1023.8% | 10-K | |
| FY2014 | $580.3M | −2.0% | 10-K | |
| FY2013 | $592.4M | −13.8% | 10-K | |
| FY2012 | $687.4M | −32.9% | 10-K | |
| FY2011 | $1.02B | −1.1% | 10-K | |
| FY2010 | $1.04B | −4.2% | 10-K | |
| FY2009 | $1.08B | −0.5% | 10-K | |
| FY2008 | $1.09B | — | 10-K |
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is BIOGEN INC.'s current long-term debt?
BIOGEN INC. (BIIB) annual long-term debt for 2025 was $6.29B, a 38.26% increase from 2024. BIOGEN INC. long-term debt for the quarter ending March 31, 2026 was $6.29B.
What was BIOGEN INC.'s long-term debt in 2024?
BIOGEN INC. annual long-term debt for 2024 was $4.55B, a 33.01% decline from 2023.
What was BIOGEN INC.'s long-term debt in 2023?
BIOGEN INC. annual long-term debt for 2023 was $6.79B, a 8.08% increase from 2022.
What is BIOGEN INC.'s 5-year long-term debt CAGR?
BIOGEN INC. long-term debt grew at a compound annual growth rate (CAGR) of 3.28% from FY2020 to FY2025, going from $7.43B to $6.29B over 5 years.
- Company
- BIOGEN INC.
- Ticker
- BIIB
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)